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INTRODUCTION 
Considering all age groups trauma is the third most frequent cause of death after 
cardiovascular and malignant diseases1. Even more significant is the fact that injury is the 
leading cause of mortality in people less than 40 years old with enormous socioeconomic 
consequences1. The postinjury mortality follows a trimodal distribution including prehospital 
mortality, early hospital mortality and late hospital mortality1. The first peak - prehospital 
mortality, responsible for 50% of all deaths - is caused by immediate deaths from high spinal 
cord injury, massive head injury, airway obstruction and exsanguinations from major 
vascular injury. This is the area where primary prevention such as education, vehicle and road 
safety and firearm control could make improvements. The second peak - early hospital 
mortality (0-48 hours), responsible for up to 30% of all deaths - is related to severe head 
injury and exsanguinations from uncontrollable bleeding and postinjury coagulopathy. To 
address these problems very efficient prehospital care with dedicated in-hospital trauma 
teams are required to work in a trauma system. The third peak - late postinjury deaths 
(usually 7-14 days), responsible for up to 20% of all deaths - is due to complications such as 
sepsis and postinjury multiple organ failure (MOF). In regions where highly developed 
trauma system exist with excellent prevention, education and prehospital care, the prehospital 
mortality is decreased, but more patients in extremis reach the hospital equalizing the 
magnitude of the first and second mortality peaks2. Despite the significant improvements in 
prehospital care, shock resuscitation and critical care, the incidence of posttraumatic MOF 
continues to be unchanged and the mortality remains high. This resulted a third peak with 
constant height in the postinjury trimodal death distribution during the last 30 years-. When 
MOF develops, no specific therapy can be instituted; the treatment modalities merely support 
the failing organs5. Extensive investigative efforts have advanced our understanding of the 
pathophysiology of MOF5112. The initial overactivation and consequent depression of the 
immune system is recognized today as the overall mechanism of postinjury MOF2 and 
polymorphonuclear neutrophil leukocytes (PMN) are identified as pivotal cellular elements of 
the postinjury inflammatory response12112. Unfortunately, these advancement in 
understanding the pathophysiology are not translated into improved outcome2. The results of 
clinical trials of newer therapeutic modalities aimed at modulating the inflammatory response 
are disappointing1^12. This failure could be largely related to the complexity of the 
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inflammatory response;16'10""1 19"20 but the early identification of high-risk patients is 
problematic as well2. Thus, 1. the identification of trauma patients at high-risk for the 
development of MOF, and 2. to concentrate our preventive efforts on the early modulation of 
the key elements of the inflammatory response in high-risk individuals are promising 
approaches to this complex problem. 
The purpose of this thesis is to discuss the improved technique of MOF prediction ("clinical 
core") and a new approach to modulate postinjury inflammatory response via the inhibition 
of PMN - endothelial cell interactions, ("basic science core") 
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CLINICAL CORE 
1. The prediction of postinjury multiple organ failure 
Background 
Based on clinical observations and extensive basic science research, the current hypothesis is 
that a dysfunctional systemic inflammatory response syndrome (SIRS) is central to the 
pathogenesis of MOF21. After the initially recommended uncontrolled infection concept22*22 it 
became obvious that postinjury MOF can occur without infections and infections are rather 
symptoms than cause of MOF24*25. However, the results of large clinical trials aimed at 
modulating the early SIRS and ultimately decreasing the incidence of MOF are not 
encouraging111115. This is partly due to the inability to identify the population at risk at an 
early stage when intervention could be effective. The Denver group of trauma surgeons and 
researchers showed that postinjury MOF can be predicted as early as 12 hours after admission 
with 63% sensitivity and 84% specificity25. They identified age, shock severity (transfusion 
requirement, metabolic acidosis) and tissue injury as independent predictors for MOF25"25. 
Age can be exactly determined and is a surrogate of physiologic reserves and co-morbidities 
which were previously shown to have poor predicting power for postinjury MOF21122. 
Parameters used for describing shock severity are either therapy-dependent, such as 
transfusion requirements, resuscitative fluid requirements and the need for inotropes or have 
limited discriminative power such as traditional measurements like blood pressure and heart 
rate22. Measures of tissue injury, in particular the Injury Severity Score (ISS), have 
consistently emerged as robust predictors of postinjury MOF26"28'31"32. However, the ISS has 
been plagued by several inadequacies22. In particular, it fails to account for multiple injuries 
to the same body region, limiting its usefulness in penetrating trauma24. The ISS is defined as 
the sum of the squares of the single highest injury score in each of the three most severely 
injured body regions. As such, the ISS fails to consider the second most severe injury from 
the already coded region in favor of less severe injuries that occur in other body regions. The 
unnatural division of the human body into regions complicates calculations and diminishes 
the predictive power. Novel measures like the Anatomic Profile (AP)22*25 and a Severity 
Characterization of Trauma (ASCOT)22 were introduced to address these shortcomings; 
however, they offered only modest gains in predicting trauma mortality25*22. Moreover, their 
computational complexity further hindered general acceptance as an alternative to the ISS. 
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Recently, Osier et al. reported a new ISS (NISS) based on the three most severe injuries, 
regardless of body region-. This simple modification of the ISS was demonstrated to 
improve mortality prediction, especially after penetrating trauma. We hypothesized that the 
NISS is also a superior predictor of postinjury MOF compared with the ISS. 
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MATERIALS AND METHODS 
Since 1992, Denver Health Medical Center, a regional Level I trauma center, has 
prospectively collected data on injured patients at risk for developing MOF. The goal of this 
prospective computerized database was to characterize the epidemiology of and identify risk 
factors for postinjury MOF. Inclusion criteria for the MOF database include age greater than 
15 years, ISS greater than 15 and survival for more than 48 hours. The present study included 
all patients entered into the database over the 5-year period ending November of 1998. The 
ISS was calculated in the standard manner as the sum squares of the highest Abbreviated 
Injury Scale (A1S) score in the three most severely injured body regions—. The NISS was 
computed as the sum of the squares of the three highest AIS scores regardless of body 
region—. Both the ISS and the NISS were based on AIS-90 scores—. Table I shows an 
example of a multiply-injured patient's scores; the NISS computation uses the three most 
severe injuries regardless of the body region. 
Table 1. Clinical example of a multiple injured patient. 
AIS 
region Injuries AIS IS f^ I 'Si 
Head Concussion 2 *)2 
¿ic*' ^  Lip laceration 1 
*>2 Chest Two fractured ribs 2 
Abdomen No injury 0 
Extremities Type C pelvic fracture 4 4
2 4 2 
Femoral shaft fracture 3 3 2 
IIIB open tibia/fibula fracture 3 32 
External Multiple abrasions 1 
Total 24 34 
MOF was defined by using the Denver MOF score21. In brief, four organ systems 
(pulmonary, hepatic, renal, and cardiac) are evaluated daily throughout a patient's intensive 
care unit stay and organ dysfunction is graded on a scale from 0 to 3 (0= no dysfunction and 
3= severe dysfunction). MOF is defined as the sum of simultaneously obtained individual 
organ dysfunction grades greater than or equal to 4. MOF is not determined before 48 hours, 
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because indices of organ dysfunction may represent incomplete or ongoing resuscitation. The 
MOF database is maintained on an IBM-compatible computer by using Microsoft Access 97 
(Microsoft Corp., Redmond, Wash). Statistical analysis was performed by using SPSS for 
Windows, Version 8.0 (SPSS, Inc., Chicago, 111) and Arcus Quickstat Biomedical for 
Windows, Version 1.0 (Research Solutions, Cambridge, UK). Where appropriate, univariate 
analysis was performed by using Student's t test for continuous data and £ square for 
categorical data. The predictive performance of the NISS was compared with that of 1SS by 
substituting it into a multiple logistic regression model containing the ISS as well as other 
risk factors for postinjury MOF. The change in predictive performance was assessed by using 
the Hosmer-Lemeshow (H-L) statistic and receiver operating characteristic (ROC) curve 
a n a ly s i s4M5 T h e R 0 C statistic is a standard measure used in trauma outcome research of the 
power of a test to separate two mutually exclusive populations. The value of the ROC means 
the area under the graph of sensitivity * 1 - specificity. A ROC value of 1 corresponds to a 
test that perfectly separates two subpopulations, whereas the value of 0.5 describes a 
completely inadequate test. The H-L statistic is used to determine how well calibrated a 
model is. The lower the value of the H-L statistic result, the better the model calibrated. 
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RESULTS 
During the 60-month study period, 558 patients admitted to the Denver Health Medical 
Center's shock/trauma 1CU who met inclusion criteria and were entered into the MOF 
database. The mean age was 36 years, and the injury was blunt in 74% (Table 2). 
Table 2. Patient demographic stratified by MOF status. 
— • — N o N Q F ~ ~ 
Parameter (n = 558) (n = 101) (n = 457) p v a l u e 
Age (yr) 36 ± 0.7 39.9 ± 1.9 35.5 ± 0.7 0.018° 
Mechanism (% blunt) 74 74 73 0.923c 
ISS 27 ± 0.4 33 ± 1.4 26 ± 0.4 <0.0001b 
NISS 33 ± 0.5 43 ± 1.4 32 ± 0.6 <0.0001b 
Transfusion (pRBC 5.3 ± 0.4 12.6 ± 1.5 3.9 ± 0.4 <0.0001b 
units/first 12 hours) 
MOF (%) 18 
Mortality {%) 9 35 2 <0.0001° 
a Continuous data shown as mean ± SEM. pRBC, packed red 
blood cell. 
5 t test MOF vs. no MOF. 
c x2 test MOF vs. no MOF. 
These patients were severely injured, as reflected by the mean ISS of 27 and average 
transfusion requirement of 5.3 units of packed red blood cells in the first 12 hours after 
injury. The mortality rate was 9%. A total of 101 patients (18%) developed MOF. Patients 
who developed MOF were older, more severely injured, and required greater transfusions 
compared with those who did not develop MOF. The mortality rate was significantly greater 
in patients who developed MOF (35% vs. 2%). The NISS and ISS scores were identical in 
271 patients (48.6%), and the NISS exceeded the ISS in 287 patients (51.4%). The subgroup 
of patients with discrepant scores differed significantly from patients with identical scores 
(XablO) 
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Table 3. Characteristics of patients with and without NISS/ISS scores 
Parameter NISS = ISS (n = 271) 
NISS > ISS 
(n = 287) p Value 
Age (yr) 37 ± 1 36 ± 0.9 0.34b 
Mechanism (% blunt) 80 67 0.001° 
Transfusion (pRBC 3.7 ± 0.5 6.8 ± 0.6 <0.0001b 
units/first 12 hours) 
MOF {%) 8.7 22.3 <0.0001° 
Mortality (%) 4.9 13.2 0.001° 
a Continuous data shown as mean ± SEM. pRBC. packed red 
blood cell. 
b t test NISS = ISS vs. NISS > ISS. 
V test NISS = ISS vs. NISS > ISS. 
Patients with discrepant scores were more likely to have suffered penetrating injuries and had 
a greater early transfusion requirement. Moreover, this group of patients had over 2.5-fold 
increase in both MOF and mortality. Graphic examination of the data demonstrates that the 
NISS discriminates between patients who did and did not develop MOF (Figs. 1 and 2V 
Figure 1. Frequency distribution of ISS for patients with and without MOF. 
ISS 
Arrows indicate median values. He difference in median ISS scores for patients with 
and without MOF is 4 (29 -25 = 4) 
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Figure 2. Frequency distribution of NISS for patients with and without MOF. 
16-25 26-35 36-45 46-55 56-65 66-75 NISS 
Arrows indicate median values. He difference in median NISS scores for patients 
with and without MOF is 13 (42 - 29 =13) 
The difference in median NISS values between patients with and without MOF was 13, 
whereas the same difference in median ISS was only 4. When the NISS was substituted for 
the ISS in a multivariate predictive model for MOF, the area under the ROC curve increased 
and the H-L statistic decreased, respectively (Table 4V 
Table 4. The results of multivariate and ROC analysis 
Parameter ISS NISS 
ROC (area under curve) 0.75 0.81 
Hosmer-Lemeshow statistic 4.923 2.366 
These changes indicate that the model including the NISS has better power to discriminate 
between patients with and without MOF and is better calibrated. Data for each model are 
shown in Table 5. 
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Table 5. Full multiple logistic regression models for predicting postinjury MOF using ISS 
and NISS. 
ISS Model NISS Model 
Variable 
Coefficient p Value Coefficient p Value 
Base deficit (mEq/L) 
< 1 0 
> 1 0 
Lactate (mmol/L) 
< 4 
> 4 
Transfusion (pRBCa 
units/first 12 hr) 
Age > 55 yr 
ISS 
NISS 
0.684 0.11 0.656 0.13 
0.696 0.12 0.704 0.13 
0.140 0.71 - 0 . 0 7 9 0.84 
0.613 0.15 0.462 0.29 
0.058 <0.0001 0.051 <0.0001 
1.017 0.0004 1.073 0.0003 
0.044 0.0001 — — 
, - 0.055 <0.0001 
pRBCs packed red blood cells. 
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DISCUSSION 
The ISS has remained the standard anatomic measure of injury severity since its introduction 
over three decades ago—. Perhaps the most notable limitation of the ISS is that it excludes 
multiple injuries of a single body region by allowing only the most severe injury in each body 
region to be considered2425. Moreover, when multiple body regions are injured, the ISS will 
ignore more severe injuries in one body region in favor of less severe injuries of another body 
region—. The AP was developed to address these limitations25125. However, the AP is 
complicated and difficult to calculate25. In addition, it was shown to be only marginally 
superior to the ISS when combined with physiologic data to predict survival2122. Although 
the ISS has been used classically to predict mortality from trauma, we and others have noted 
it to be a consistently good indicator of risk for postinjury MOF26"282'. In developing 
predictive models for MOF, the risk factors were categorized as being related to tissue injury 
severity, cellular shock severity, the magnitude of the systemic inflammatory response to the 
injury, and host factors (including age, sex, and co-morbidity)2*22128. Tissue injury severity is a 
major component of the MOF predictive models; and we have considered it to be readily 
quantifiable by using the ISS. Recognizing the limitations of the ISS, the AP was 
subsequently investigated AP as an alternative measure of tissue injury severity. However, 
we observed that the AP offered no advantage over the ISS in predicting postinjury MOF28. 
Moreover, the AP is difficult to calculate with greater inter-rater variability compared with 
the ISS28. The NISS is a simple but significant modification of the ISS—. By considering the 
three most severe injuries regardless of body region, it avoids many of the previously 
acknowledged limitations of the ISS. By preserving the AIS as the framework for injury 
severity scoring, the NISS remains familiar and "user friendly." Preliminary studies suggest 
that the NISS is a more accurate predictor of trauma mortality than the ISS42"45. Osier et al. 
recommended that the NISS replace the ISS as the standard anatomic measure of injury 
severity42. This report extends these observations and demonstrates that the NISS is a 
superior predictor of postinjury MOF. The difference in median NISS scores between 
patients with and without MOF was greater than the difference in median ISS scores; thus, 
better separating these two groups of patients. Moreover, a multivariate predictive model 
incorporating other risk factors for postinjury MOF showed that substituting the NISS for the 
ISS in the model yielded better predictive performance. This improvement is reflected in an 
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increase in the area under the ROC curve and a decrease in H-L statistic. Over half of the 
patients had NISS scores exceeding their ISS scores. This subgroup of patients had an almost 
threefold higher incidence of MOF and mortality compared with the group in whom the ISS 
equaled the NISS. There were more male patients in the NISS>ISS group, most likely 
reflecting the greater frequency of penetrating injuries among men. Our observation that 
penetrating injuries were greater in the NISS>ISS group (33% vs. 20%) supports this 
assumption. Moreover, further examination of our MOF database showed penetrating injury 
in 32% of male patients compared with 11% of female patients. We conclude that the NISS is 
superior to the ISS in the prediction of postinjury MOF. Given its greater simplicity and ease 
of calculation, it should replace the ISS as the preferred measure of tissue injury severity. 
Moreover, it seems that the subgroup of patients whose NISS exceeds their ISS is at high risk 
for MOF and deserves closer study. 
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2. The predictive power of NISS applied for the entire trauma population - the Szeged 
experience 
Background 
The improved predictive power of the NISS over the ISS has been demonstrated in mortality 
and MOF prediction424242. The ISS also underestimates multiple orthopedic injuries (MOI) in 
Polytrauma scenarios and has been found to be a poor predictor of postinjury hospital length 
of stay (LOS)2142. The NISS was never tested in the European trauma system where the 
dominant injury mechanism is blunt and all minor and low energy traumas are managed in 
the trauma departments. In Hungary the regionalized trauma system is under development. 
The other important feature of the Hungarian trauma care is that extended hospital length of 
stay (LOS) on trauma departments often occurs because of multiple orthopedic trauma. With 
the use of the traditional ISS (only the single highest injury is counted in a region) this 
problem is not recognized. Based on the German and the United States experience it is 
essential to designate trauma centers with adequate patient load to maintain the trauma care 
Personnel's injury management skills42^. The establishment of the trauma system is key 
contributor to the prevention of MOF. Firstly, it is supposed to decrease the time until 
hemorrhage control (shock is an independent predictor of MOF) and secondly, the high risk 
Patients could get access to the specialized critical care environment. The accurate trauma 
center and intensive care unit (ICU) design mandates the estimation of the injury severity-
matched length of hospitalization and the need for ICU beds of a given region's trauma 
Population. Unfortunately this calculation can not be accurately performed on the basis of 
international figures where the injury mechanisms and hospital and ICU LOS days are not 
applicable because of the local social, economic and inffastructural characteristics. We aimed 
1. to compare the scoring efficacy of the ISS and the NISS in predicting extended hospital 
LOS and ICU admission, and 2. to determine the effect of MOI on the discrepancies between 
the ISS and NISS (the previously described high risk NISS>ISS group) and their impact on 
extended LOS and ICU admission in the region of Szeged. 
MATERIALS AND METHODS 
A total of 3,100 consecutive patients over the two years period ending on December 31, 
2000, admitted to the Department of Traumatology, University of Szeged, who met the 
inclusion criteria of age older than 14 years and survival greater than 24 hours were entered 
into the study. Data on gender, age, co-morbid conditions, all AIS scores for each of the six 
body regions, hospital LOS, and ICU admission were collected prospectively in the study 
registry, unaffected by the discharge coding and financial interest of the department. The ISS 
and the NISS were prospectively calculated. The ISS was calculated in the standard fashion 
as the sum of the squares of the highest AIS scores in the three most severely injured body 
regions-. The NISS was computed as the sum of the squares of the three highest AIS scores 
regardless of body region42. For the computation of both scores, the AIS-90 version was 
used42. When a patient's NISS was higher than the ISS, the responsible AIS region was noted 
(in the example in lafak-X the marked region is the extremity region). The computation of 
the scores was performed prospectively by three physicians of the department. Intra-rater and 
inter-rater reliability studies showed excellent reproducibility (>95% for ISS and >98% for 
NISS). Where appropriate, univariate analysis was performed using Student's t test for 
continuous data, and x2 square for categorical data. Data are depicted as percentages or mean 
± standard error of mean (SEM). The ISS and NISS were compared as univariate predictors 
of extended hospital LOS and ICU admission. Multivariate analysis was used to determine if 
substitution of the NISS for the ISS resulted in a superior predictive model. The predictive 
Performance of the NISS was compared with that of the ISS by substituting it into a multiple 
logistic regression model containing the ISS and other possible risk factors for postinjury 
extended LOS and ICU admission. The ISS model included age, gender, co-morbidity, and 
the ISS. The NISS model included the same, but the ISS was replaced by the NISS. The 
change in predictive performance was assessed using the H-L goodness-of-fit statistics and 
ROC)curve analysis4245. The subgroup of patients with discrepant scores (NISS > ISS) was 
evaluated further to determine the potential input of MOI in patients with extended LOS and 
ICU admission. The prospective database was maintained on an IBM compatible computer 
using Microsoft Access 97 (Microsoft Corp, Redmond, WA). Statistical analysis was 
Performed using SPSS for Windows, Version 8.0 (SPSS, inc, Chicago, IL). 
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RESULTS 
3,100 consecutive patients with the average 1SS of 6 ± 0.13 (median 6, range 1-48) were 
included into this prospective study. There were 1,799 (58%) male patients; the average age 
of the population was 48 ± 0.5 years (range 15-94). Within the cohort, 42% had significant 
co-morbidity requiring medication during the hospitalization. Only patients, 230 (7.5%) had a 
higher NISS (mean 12.8 ± 0.8, median 13, range 2-54) than ISS (mean 7.1 ± 0.6, median 6, 
range 1-43); while 2,870 cases (92.5%) had equal NISS and ISS (mean 5.8 ±0.1, median 6, 
range 1-48). 
The incidence of MOI among patients with identical scores was only 0.8% (230 of 2,870 
patients) compared with 70% (161 of 230) of patients with discrepant scores (p < 0.0001) 
(Fig. 1). The results of the univariate analysis comparing NISS = ISS and NISS > ISS groups 
(Xable 61 showed a significantly longer hospital LOS (8 ± 0.2 versus 22 ± 1.6 days; p < 
0-001 - and ICU LOS (0.1 ± 0.02 versus 3.4 ± 0.6 days; p < 0.001) and more frequent ICU 
admission (1.8% versus 34%; P < 0.001) in the group with discrepant scores. 
Table 6. Univariate comparison of patients with equal (NISS = ISS) and discrepant (NISS > 
ISS) scores. 
Age ISS Comorbidity Mortality 
Hospital 
LOS 
ICU 
admission 
ICU 
LOS 
NISS >ISS 
NISS = ISS 
48 + 2 7.2+1 
50 ±1 5.8 + 1 
),6 41% 
11 42% 
X%* 
1.2% 
22+1.6* 
8 + 0.2 
34%* 
1.8% 
3.4+0.6* 
0,1+0,02 
*P< 0.001. 
The NISS > ISS group had a significantly (p< 0.001) higher mortality (8%) than the NISS = 
ISS group (1.2%) despite their similar age, ISS, and co-morbidity. Data for the extended 
hospital LOS and ICU admission multivariate models for the entire cohort are shown in 
Tables 7 and S 
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Table 7. Multiple logistic regression analysis for predicting extended (> 10 days) hospital 
length of stay. 
ISS model NISS model 
Coeff ic ient P value Coeff icient P value 
Gender 
Age 
Comorbidi ty 
ISS 
NISS 
- 0 . 2 0 6 
0 ¡»025 
0 .876 
0.165 
0 .113 
<0.0001 
0 .233 
<0.0001 
- 0 , 2 3 2 
0 ,026 
0,692 
0 .146 
0 .0766 
<0.0001 
0 .198 
<0.0001 
Table 8. Multiple logistic regression analysis for predicting intensive care unit admission. 
ISS model NISS nv ode I 
Coeff ic ient P value v06111C16111 P value 
Gender 
Age 
Comorbidi ty 
* 
A&St 
NISS 
0 .577 0.0742 
0 .0017 0.807 
0 .267 0 .764 
0 .317 <0.0001 
0*492 
0 .0075 
0 . 4 ) 4 
0.275 
0.141 
0.331 
0 .627 
<0.0001 
Based on multiple logistic regression analysis, the independent predictors (P < 0.0001) of 
extended hospital LOS are age, ISS, and NISS; the independent predictors (P < 0.0001) for 
ICU admission are the anatomic injury measures, ISS, and NISS. The model that included 
NISS was found to be more predictive of longer (>10 days) LOS (ROC: NISS = 0.794, ISS = 
0.782; P < 0.0001) and ICU admission (ROC: NISS = 0.944, ISS = 0.918; P < 0.0001). The 
multivariate predictive model that included NISS showed a better goodness of fit (H-L for 
long LOS NISS = 11.58, ISS = 14.82; H-L for ICU admission NISS = 5.42, ISS = 6.32) 
compared with the same model that included ISS. In both multivariate predictive models 
when the NISS was substituted for the ISS, the areas under the ROC curves increased, and 
the H-L statistics decreased ITahle 9). 
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Table 9. Results of multivariate ROC analysis. 
Extended LOS ICU admission 
prediction prediction 
ISS NISS ISS NISS 
ROC (area under the curve) 0.772 0.788* 0.91H 0,944* 
H o s m e r - L e m e s h o w statistic 14.82 11.58 6 .32 5 .42 
*P < 0.00 L 
These changes indicate that the model including the NISS has a better power to discriminate 
between patients with extended and non-extended hospital LOS and between patients who 
were admitted and were not admitted to the ICU. We evaluated further the high-risk group of 
patients with NISS > ISS. Among patients with discrepant scores, 61% (140 patients) had 
MOI (extremities) responsible for the NISS > ISS. The other AIS body regions responsible 
for score discrepancies were abdomen, 15% (34 patients); head, 8% (18 patients); external, 
6% (14 patients); chest, 5% (12 patients); and face, 5% (12 patients). 
DISCUSSION 
The ISS underestimates MOI in polytrauma scenarios and is found to be a poor predictor of 
postinjury LOS44151. The unnatural division of the human body into regions complicates the 
calculation and diminishes the predictive power42. The Anatomic Profile (AP) and the 
combined anatomic and physiologic scores, such as TR1SS and ASCOT (A Severity 
Characterization of Trauma) were introduced to address these shortcomings; however, they 
offered only modest gains in predicting trauma mortality28. Their computational complexity 
and poorer intra-rater and inter-rater reciprocity further hinder general acceptance as an 
alternative to the ISS—. These facts helped the ISS to survive for three decades as the most 
extensively used anatomic measure. Recently the NISS has been proved to be a better 
predictor of postinjury death and MOF. The ISS is unable to discriminate patients with 
multiple extremity trauma from the rest of the trauma population. Although this group can be 
the major cause of increased health care costs, it is still undiscovered by the traditional injury 
scoring48'51,53. Simultaneous calculation of the ISS and the NISS in the present study revealed 
that patients with discrepant scores (NISS > ISS) spent a longer time in the hospital and in the 
ICU and were admitted to the ICU more frequently. By definition, the NISS is always equal 
to or higher than the ISS; if the NISS is higher, it means that a significant injury or injuries 
are taken into account that would have been neglected by the ISS (Table 11. Our results on 
mortality support the finding of other groups that the NISS > ISS group is more likely to have 
a poor outcome. The ISS and NISS were defined as independent predictors of extended 
hospital LOS and ICU admission. The multivariate predictive models that included the NISS 
outperformed models that included the ISS. The areas under the ROC curves are significantly 
higher in the NISS models than the ISS models. Both scores did better in predicting ICU 
admission than extended hospital LOS. The reason for this could be that ICU admission is 
more closely related to threat of life than extended hospital LOS. The ISS was not designed 
for the evaluation of resource utilization, but the NISS did better in this field. Many studies 
showed that the ISS underestimates the increased morbidity and resource utilization related to 
multiple extremity injuries4215152. The application of the NISS offers an answer to this 
Problem. In most (61%) of the patients with NISS > ISS, the orthopedic injuries were 
responsible for the higher value of the new scoring system. The high-risk group causing extra 
hospital charges (two thirds of the NISS > ISS group spent >10 days in the hospital, and 37% 
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of the patients were admitted to the ICU) is recognized by the use of the NISS but hidden for 
an ISS-based database. Similar to previous comparisons of ISS and NISS for predicting 
postinjury death and MOF, our results indicate that the NISS is a superior predictor for 
extended posttraumatic hospitalization and the need for ICU admission. 
In summary it can be concluded that: 
1. The NISS is a better predictor of the postinjury extended hospital LOS and ICU 
admission than the ISS. 
2. Trauma patients with discrepant (NISS > ISS) scores are admitted to the ICU more 
frequently and have longer hospital and ICU LOS with increased mortality rate. 
3. Because in most patients the discrepancy between ISS and NISS is due to MOI, 
orthopaedic trauma has a major effect on trauma outcomes such as hospital and ICU 
LOS, ICU admission, and mortality rate. 
4. Since the NISS disregards the anatomic regions, calculations are easier and give extra 
accuracy to the new anatomic measure. 
Most importantly, our study adds a further reason to consider the replacement of the 
traditional ISS by the NISS in trauma outcome research. 
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BASIC SCIENCE CORE: Modulation of the postinjury immune response for the 
prevention of multiple organ failure 
Background 
The combination of posttraumatic/hemorrhagic shock (HS) and subsequent resuscitation is 
associated with ischemia-reperfusion (I/R) injury in the systemic circulation. I/R-induced 
PMN adhesion and extravasation are strongly associated with posttraumatic complications, 
including systemic inflammatory response syndrome, multiple organ dysfunction syndrome, 
and MOF2*12. For the initiation of leukocyte migration and activation, interaction with the 
endothelial layer is necessary51. The first phase of PMN adhesion is mainly dependent on 
selectins55. These adhesion molecules share a common primary structure with an N-terminal 
lectin domain that interacts with various glycoconjugated ligands, including heparan sulfate 
and heparin-, and this raises the possibility that heparin-like oligosaccharides can inhibit L-
selectin- and P-selectin-mediated PMN adhesion52. Although the potential to inhibit 
leukocyte-endothelial cell interactions could alter the harmful consequences of I/R, the 
clinical applicability of conventional heparin is limited because of the increased risk of 
bleeding. Low-molecular weight heparins (LMWHs) are much safer in this regard52^. 
LMWHs are used extensively in posttraumatic situations, as they are potent and safe 
thromboprophylactic agents52. However, it may be hypothesized that the advantageous 
properties might include a so far unknown effect on leukocyte-endothelial cell interactions. 
Accordingly, the aims of our experimental work were 
1. to observe and quantify HS and reinfusion-induced leukocyte-endothelial cell 
interactions in the mesentery in a large animal model; 
2. to evaluate the consequences of LMWH pretreatment on leukocyte-endothelial cell 
interactions after HS; 
3. to compare the effects of LMWH and conventional UFH (heparin sodium) 
pretreatments; 
4. and to evaluate the effectiveness of late LMWH therapy, when the treatment was 
initiated only after HS and resuscitation was performed with crystalloid. 
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MATERIALS AND METHODS 
The experiments were performed in adherence to the National Institutes of Health guidelines 
for the use of experimental animals. The study was approved by the Ethical Committee for 
the Protection of Animals in Scientific Research of the University of Szeged. Seven groups of 
healthy mongrel dogs (mean body weight, 12.5 kg; range, 9.8-14.3 kg) were used ( B f U ) 
Figure 3. Experimental group and protocol (See Material and Methods for the description of 
the groups) 
MAP- 40, 60 minutes shock period with mean arterial pressure of 40 mmHg; UFH, 
unfractionated heparin; Dalteparin, Dalteparin sodium; Resus: blood, resuscitation with 
shed blood; Resus LR, resuscitation with lactated Ringer's solution, s.c., subcutaneous; i.v„ 
intravenous; IVM, intravital video microscopy. 
IVM recordings 
Group 
Group 2 MAP-40 I Resus: blood 
Group 3 UFH s.c. M \P~40 I Resus: blood 
Group 4 Dalteparin s.c. MAP-40 I Resus: blood 
Group 5 
Group 6 
M AP-40 | Resus: blood 
Dalteparin ¡.v. 
MAP-40 Resus: LR li V ill if I iftil fl ! H Ill'' III! I I fill I 111 
Croup 7 Dalteparin s.c. 1 
•60 min 
MAP-40 Resus: LR 
0 min 60 min 120 min 180 min 
The animals were intubated and anesthetized with sodium pentobarbital (30 mg/kg 
intravenously [i.v.] for induction, 2 mg/kg for supplementary doses); the body temperature 
was maintained at 37°C with a homeothermic blanket. The left femoral artery and vein were 
cannulated for the measurement of mean arterial pressure (MAP), and for the administration 
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of fluid (7 mL/kg/h lactated Ringer's [LR] solution; B. Braun, Melsungen, Germany) or 
drugs, the reinfusion of shed blood, and resuscitation with LR solution, respectively. The 
right femoral artery was cannulated and connected to a reservoir, and a midline laparotomy 
was performed for visualization of the mesenteric microcirculation of the small bowel. Group 
1 (n= 5) served as sham-operated control to exclude hemodynamic changes attributable to the 
time elapsed. In groups 2 through 7, HS was achieved by bleeding the animals into the 
reservoir (to MAP ~ 40 mm Hg), and after hypotension lasting 60 minutes, the shed blood 
was reinfused (groups 2-5) or resuscitation was performed with LR solution (groups 6 and 
7). In group 2 (n= 8), no additional treatment was given (untreated controls). Group 3 (n= 7) 
was treated with 5,000 IU UFH subcutaneously (s.c.) (heparin sodium, Merckle-Ratiopharm, 
Ulm, Germany) before the induction of hemorrhage. Group 4 (n= 7) was pretreated with 
5,000 U LMWH s.c. (dalteparin sodium, Pharmacia, Peapack, NJ, USA). In group 5 (n= 8), 
100 U/kg LMWH was administered in an i.v. bolus injection at the onset of the resuscitation. 
In groups 6 and 7, the resuscitation was performed with LR solution with a volume four times 
greater than the shed blood volume. Group 6 (n= 7) received no further treatment, whereas 
group 7 (n= 8) was pretreated with 5,000 U LMWH s.c. During the experiments in the 
pretreated groups, the clinically relevant safe thromboprophylactic doses were used for UFH 
and LMWH; these doses are recommended for the prevention of deep venous thrombosis in 
high-risk patients regardless of body weight. In group 5, where the LMWH administration 
was at the end of the shock period, the i.v. route was preferred because of the uncertainty of 
the peripheral circulation. The i.v. bolus of 100 U/kg is recommended for patients with deep 
venous thrombosis 1 hour before the continuous i.v. administration is initiated when the 
peripheral circulation is impaired. The mesenteric microcirculation was monitored by means 
of intravital fluorescence video microscopy. The exposed mesentery with intact 
neurovascular connections was gently placed on a specially designed stage to minimize organ 
movements caused by the breathing of the animals. The tissues were continuously superfused 
with 36.5°C saline to avoid drying and exposure to ambient air and to maintain the water 
immersion of the microscope objectives. Any exposed tissue not protected by glass was 
covered by plastic sheets. Leukocytes were stained in vivo by means of rhodamine-6G (Mw 
479, Sigma Chemical Co., St. Louis, MO; 0.2%, 1 mL i.v. 2 minutes before measurements) 
and the mesenteric microcirculatory network was visualized using a high-resolution Zeiss 
29 
Axiotech Vario 100HD (Carl Zeiss, Thornwood, NY) fluorescence intravital microscope (100 
W HBO mercury lamp, Aeroplán (Carl Zeiss) water immersion objective). The microscopic 
images were recorded by a charge-coupled device video camera (AVT HORN-BC 12 [AVT 
HORN, Aalen, Germany]) attached to an S-VHS video recorder (Panasonic AG-MD 830) 
and a personal computer. Quantitative assessment of the microcirculatory parameters was 
Performed off-line by frame-to-frame analysis of the videotaped images using a computer-
assisted image analysis system (IVM Pictron, Budapest, Hungary). Leukocyte-endothelial 
cell interactions were analyzed within five fields per animal, including the observation of 
non-adherent, adherent, and rolling leukocytes in five postcapillary venules per field. 
Adherent leukocytes (stickers) were defined in each vessel segment as cells that did not move 
or detach from the endothelial lining within an observation period of 30 seconds, and are 
given as numbers of cells per square millimeter of endothelial surface, calculated from the 
diameter and length of the vessel segment observed, with the assumption of cylindrical 
geometry. Rolling leukocytes were defined as cells moving at a velocity less than two fifths 
that of erythrocytes in the centerline of the microvessel, and are given as percentages of non-
adherent leukocytes passing through the observed vessel segment within 30 seconds. The 
animals were randomly assigned to the various experimental groups. After a stabilization 
Period, basal cardiovascular parameters were measured for 20 minutes, IVM was then 
Performed to establish the baseline microvascular variables in all groups. Video microscopic 
•mages were recorded before hemorrhage (-60 minutes), at the end of the 60-minute HS 
period just before reinfusion/resuscitation (0 minutes), and at 60, 120, and 180 minutes after 
resuscitation. At the end of the experiments, the animals were killed with an overdose of 
Pentobarbital. The statistical analysis was performed with a statistical software package 
(SigmaStat for Windows, Jandel Scientific, Erkrath, Germany). Friedman repeated measures 
analysis of variance on ranks was applied within the groups. Time dependent differences 
from the baseline (0 minutes) for each group were assessed by the Dunn method. Differences 
between groups were analyzed with Kruskal-Wallis one-way analysis of variance on ranks, 
followed by the Dunn method for pair wise multiple comparison. Figures present median 
values and 75th and 25th percentiles; p values < 0.05 were considered significant. 
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RESULTS 
MAP was unchanged in the sham-operated group (group 1) during the examination period, 
and no changes in leukocyte-endothelial cell interactions were observed as compared with the 
baseline level. In groups 2 through 7, MAP was kept at 40 mm Hg during the HS period; after 
resuscitation, MAP values reached the pre-HS level regardless of the type of resuscitation 
Figure 4. Mean arterial pressure changes during the observation period. 
*P <0.05 within group; Xp <0.05 between sham-operated and HS groups. See Materials and 
Methods section for statistical evaluation. HS, hemorrhagic shock; UFH, unfractionated 
heparin; Dalteparin, dalteparin sodium; LR, lactated Ringer's (solution); s.c., 
subcutaneous; ¿v., intravenous. 
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In the untreated control group, HS and reinfusion significantly increased leukocyte rolling in 
the mesenteric postcapillary venules, from a mean baseline value (-60 minutes) of 22.5% to 
61%, 76%, 80%, and 87% at 0, 60, 120, and 180 minutes, respectively (Fig. 5). 
Figure 5. The percentage of rolling leukocytes in mesenteric postcapillary venules with UFH 
or dalteparin sodium pretreatment before HS 
followed by resuscitation with shed blood. 
*p <0.05 within group; xp <0.05 between sham-operated and HS groups; ftp <0.05 between 
untreated and treated groups. See Materials and Methods section for statistical evaluation. 
HS, hemorrhagic shock; UFH, unfractionated heparin; Dalteparin, dalteparin sodium; s.c., 
subcutaneous. 
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Firm adhesion increased from a baseline value of 56 cells/mm2 to 479, 818, 1,636, and 1,128 
cells/mm2 at 0, 60, 120, and 180 minutes after hemorrhage, respectively (Fig. 6). 
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Figure 6. The number of adherent leukocytes in mesenteric postcapillary venules with UFH 
or dalteparin sodium pretreatment before HS followed by resuscitation with shed blood (in 1 
mm vessel area). 
*p <0.05 within group; xp <0.05 between sham-operated and HS groups; ftp <0.05 between 
untreated and treated groups. See Materials and Methods section for statistical evaluation. 
HS, hemorrhagic shock; UFH, unfractionated heparin; Dalteparin, dalteparin sodium; s.c., 
subcutaneous. 
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In the UFH-treated group 3 , the percentage of rolling and the number of adherent leukocytes 
did not differ statistically from those observed in untreated group 2 with HS (Figs. 5 and M 
The subcutaneous dalteparin sodium pretreatment in group 4 decreased the rolling fraction of 
the leukocytes to 21%, 39%, 43%, and 35.5%, and the firm adhesion to 282, 290, 522, and 
2 9 6 cells/mm2 at the same consecutive recording times. 
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In group 5, when LMWH was administered at the time of resuscitation, the number of 
leukocyte-endothelial interactions did not differ from that in the untreated group 2 at 60 
minutes and 0 minutes. However, at the postresuscitation time points (60, 120, and 180 
minutes), the rolling fraction decreased to 24.5%, 28%, and 49%, respectively, and the 
absolute numbers of adherent leukocytes were significantly lower (367, 345, and 409 
cells/mm2, respectively) (Figs. 7 and 8V 
Figure 7. The percentage of rolling leukocytes in mesenteric postcapillary venules with 
dalteparin sodium pretreatment (before HS) and treatment (at the end of HS) followed by 
resuscitation with shed blood. 
*p <0.05 within group; xp <0.05 between sham-operated and HS groups; #p <0.05 between 
untreated and treated groups. See Materials and Methods section for statistical evaluation. 
HS, hemorrhagic shock; Dalteparin, dalteparin sodium; s.c., subcutaneous; /.v., intravenous. 
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Figure 8. The number of adherent leukocytes in mesenteric postcapillary venules with 
dalteparin sodium pretreatment (before HS) and treatment (at the end of HS) followed by 
resuscitation with shed blood (in 1 mm2 vessel area). 
*p <0.05 within group; xp <0.05 between sham-operated and HS groups; #p <0.05 between 
untreated and treated groups. See Materials and Methods section for statistical evaluation. 
HS, hemorrhagic shock; Dalteparin, dalteparin sodium; s.c., subcutaneous; /.v., intravenous. 
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In group 6, the HS and the resuscitation with LR solution significantly increased the 
leukocyte-endothelial cell interactions. The leukocyte rolling increased from the baseline 
11% (-60 minutes) to 63%, 87%, 88%, and 90% at 0, 60, 120, and 180 minutes, respectively. 
The number of adherent cells increased from the baseline value of 55 cells/mm2 to 1,818, 
3,999, 4,109, and 5,199 cells/mm2 at 0, 60, 120, and 180 minutes after resuscitation (Figs. 9 
and 10T 
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Figure 9. The percentage of rolling leukocytes in mesenteric postcapillary venules with or 
without dalteparin sodium pretreatment before HS followed by resuscitation with lactated 
Ringer's solution. 
*p <0 05 within group; Xp <0.05 between sham-operated and HS groups; ftp <0.05 between 
untreated and treated groups. See Materials and Methods section for statistical evaluation. 
HS, hemorrhagic shock; Dalteparin, dalteparin sodium; LR, lactated Ringer's (solution); 
s.c., subcutaneous. Dalteparin Sodium Treatment during Resuscitation 
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Figure 10. The number of adherent leukocytes in mesenteric postcapillary venules with or 
without dalteparin sodium pretreatment before HS followed by resuscitation with lactated 
Ringer's solution (in 1 mm2 vessel area). 
*p <0.05 within group; xp <0.05 between sham-operated and HS groups; #p <0.05 between 
untreated and treated groups. See Materials and Methods section for statistical evaluation. 
HS, hemorrhagic shock; Dalteparin, dalteparin sodium; LR, lactated Ringer's (solution); 
s.c., subcutaneous. 
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No/mm * 
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In group 7, the dalteparin sodium pretreatment significantly reduced the interactions in the 
small bowel mesenteric microcirculation after LR resuscitation, similar to that observed in 
shed blood-resuscitated group 4. After LMWH pretreatment, the rolling fraction of 11% (-60 
minutes) increased to 34% (0 minutes), 39% (60 minutes), 39% (120 minutes), and 37% (180 
minutes), and the adherent cell number of 60 cells/mm2 (-60 minutes) increased to 327 
cells/mm2 (0 minutes), 473 cells/mm2 (60 minutes), 545 cells/mm2 (120 minutes), and 618 
cells/mm2 (180 minutes) in the LR-resuscitated group 7 (Figs. 9 and 10) 
74 
D I S C U S S I O N 
Despite the improvements in perioperative and postoperative care, the incidence of 
posttraumatic M OF continues unchanged and the mortality remains high4. When MOF 
develops, no specific therapy can be instituted; the treatment modalities merely support the 
failing organs5. Thus, the prevention of postinjury organ dysfunction with adequate 
resuscitative methods must be a key element of early interventions to achieve effective 
modulation of the inflammatory response54. As the combination of HS and resuscitation 
(whole-body I/R) causes damage to the intestinal microcirculation, the reperfused gut might 
be the engine of the postinjury complications. In our animal model, HS significantly 
increased the leukocyte-endothelial cell interactions in the mesenteric postcapillary venules, 
and s.c. administered LMWH pretreatment significantly inhibited the effect of I/R injury on 
leukocyte adherence. In contrast with previous studies, these cell-to-cell interactions were not 
prevented by UFH treatment. It is important to note that in these in vitro studies the cell 
layers were perfused with pharmacologic doses of UFH, which are difficult to apply in 
clinical scenarios52. However, these investigations clearly revealed the properties of 
glycosaminoglycans as ligands to the selectins, which are essential molecules of the 
leukocyte-endothelial cell interactions—. Heparin, isolated form porcine intestinal mucosa or 
bovine lung, is a glycosaminoglycan composed of alternating D-glucosamine and uronic acid 
residues that are heterogenous in size (3-30 kDa) and degree of sulfation. The significant 
differences between UFH and LMWH may be derived from different characteristics of 
binding to the adhesion molecules and/or the better bioavailability of the LMWH molecules 
after s.c. administration. The molecular mass range of sodium dalteparin sodium is 3 to 8.5 
kDa, whereas the molecular mass of UFH is 3 to 30 kDa55. The smaller molecules cause 
fewer bleeding complications, but the compounds are still too heavily sulfated to be effective 
ligands for adhesion molecules. The pharmacokinetics of s.c. LMWH are also favorable. 
Dalteparin sodium exhibits dose-independent monoexponential first-order pharmacokinetic 
characteristics, usually expressed in terms of plasma anti-factor Xa activity. A mean 
maximum plasma anti-factor Xa activity value of 290 U/L was reported after s.c. 
administration of 5,000 U dalteparin, and 180 U/L after the same dose of UFH. The 
bioavailability of dalteparin sodium after s.c. administration is 87%, as compared with 
approximately 25% for UFH52. Pretreatment with anticoagulants and resuscitation with 
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autologous blood is very different from routine clinical practice. Our study involved three 
additional groups (groups 5-7) to eliminate these biases. An important secondary finding was 
that, in the untreated groups, the number of adherent cells was about three times higher if 
resuscitation was performed with LR solution (group 6) compared with shed blood 
resuscitation (group 2). Nevertheless, the type of resuscitation (shed blood vs. crystalloid) did 
not affect the tendencies to leukocyte rolling and adhesion after hemorrhagic shock (but did 
affect the absolute number of adherent cells), and did not influence the effectiveness of 
LMWH to prevent adhesion. The post-HS dalteparin sodium treatment was administered i.v., 
because of uncertain absorption from subcutaneous sites during the shock state. Without 
LMWH pretreatment, similar leukocyte reaction occurred before and during HS to those 
observed in the untreated controls. However, i.v. dalteparin sodium administration at the time 
of resuscitation significantly decreased the number of interactions in the postresuscitation 
period. It is unlikely that the molecule has any effect on an established leukocyte-endothelial 
cell interaction, but our results suggest that this treatment can prevent amplification of the 
process. The significant decrease in the number of adherent cells is because of the 
extravasation of previously adhering leukocytes and the LMWH medication-induced relative 
decrease in newly evolving adhesions. It should be mentioned here that LMWHs are not 
interchangeable: their pharmacologic characteristics might differ in association with their 
different structural properties58. In view of the effectiveness of LMWH treatment, the 
inhibitory effects of dalteparin sodium on leukocyte rolling and adherence deserve further 
investigation. Our further studies should focus on showing that the decrease of leukocyte-
endothelial cell interactions could result in lower incidence of MOF. In conclusion: 
1. We propose that pharmacologically relevant doses of the LMWH compound (in 
addition to thromboprophylaxis) exert beneficial effects through modulation of the 
leukocyte-mediated early inflammatory responses, and this property may be important 
for the prevention of posttraumatic complications in human clinical practice. 
2. In the absence of contraindication, the initiation of LMWH administration should be 
considered in trauma patients after hemorrhage control. 
78 
CLINICAL IMPLICATIONS AND FLTLRE DIRECTIONS 
Prospective data analyzed with uni- and multivariate methods consistently prove age, shock 
severity and injury severity as independent risk factors for postinjury MOF25,12. 
Elderly patients (>55 years is independent risk factor) present significant challenge to 
European and North American trauma care providers where increasing proportion of the 
population falls into this category. The aging of the population is an important reason for the 
consistency of MOF incidence despite the more sophisticated intensive care knowledge and 
technology1. 
Basic and clinical research indicates that traumatic shock is a major contributor of postinjury 
MOF2. The timely recognition and control of hemorrhage together with optimal resuscitation 
are essential parts of the prevention of HS related complications such as MOF. To achieve 
this universal systematic response is required to all major trauma patients' resuscitation. The 
already proven approach is recommended by the Advanced Trauma Life Support Program 
(ATLS), which standardizes the first hour of trauma patients' inhospital evaluation and 
management driven by priorities-. This is a very different approach compared to our medical 
training where after the detailed history one performs meticulous physical examination, order 
tests, requests consults from other specialties and finally have a diagnosis which makes it 
possible to initiate treatment. The ATLS supports the standardized diagnostic test 
simultaneously with the focused history and checking the vital organ systems. Invasive 
interventions (therapy) are encouraged on the basis of clinical signs without diagnosis (i.e. 
decreased breath sounds on the right chest means chest tube insertion without knowing what 
is the underlying cause). Based on the explored inadequacies in the Hungarian trauma care 
the introduction of the ATLS program is an appropriate next step to address the 
shortcomings22. Our working group's efforts since 1997 have led the promulgation process to 
the first Hungarian course in 2005. Finding the ideal approach to traumatic resuscitation is 
complex and well exceeding the aims of this thesis. Our basic science findings however 
indicate that LMWH administration is a useful adjunct to shock resuscitation in preventing 
leukocyte-endothelial cell interactions the known initial step of PMN (key cellular element in 
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the mechanism of postinjury MOF) activation-. The fact that the magnitude of interactions 
(both rolling and adhesion) is higher if resuscitation is performed with LR than shed blood is 
an important additional finding which a potential impact on our clinical trauma care. 
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Independently from our results other groups in different models have proven the pro-
inflammatory characteristics of LR. Given the fact that LR is one of our first-line 
resuscitation crystalloid fluid this finding has significant clinical relevance22122. 
It is not possible to modulate the anatomical injury after the trauma but it can be exactly 
described and compared within and between centers. The latter fact makes anatomical scores 
very important in trauma outcome and prediction research—. Contrary its widespread 
application during the last three decades the ISS has several inadequacies12115. We could show 
that the NISS preserves and even further develops the ISS simplicity and improves its 
accuracy and predictive power. The NISS is a superior predictor of MOF over the ISS12. Our 
study performed on the entire trauma population showed that the NISS is more accurate in 
predicting general trauma outcomes such as mortality, hospital LOS and ICU admission21. 
S U M M A R Y 
The thesis presents NISS, a new, improved anatomic measure to predict postinjury MOF, 
which helps to concentrate our preventive and therapeutic efforts to the right population of 
patients. In addition, new areas are opened for further research to prevent postinjury MOF. 
We propose new adjuvant therapy with sodium dalteparin, a potent modulator of the 
uncontrolled leukocyte-endothelial cell interactions; and we draw attention to the potential 
threats of LR as a pro-inflammatory agent in resuscitation and trauma care. 
82 
REFERENCES 
1. Committee on Trauma Research, Commission on Life Sciences, National Research 
Council and the Institute of Medicine. Injury in America. Washington DC: National 
Academy Press; 1995. 
2. Baker CC, Oppenheimer L, Stephens B, Lewis FR, Trunkey DD. Epidemiology of 
Trauma Deaths. Am J Surg. 1980;140:144-150. 
3. Sauaia A, Moore FA, Moore EE, et al. Epidemiology of trauma deaths: a 
reassessment. J Trauma. 1995;38:185-193. 
4. Baue AE, Durham R, Faist E. Systemic inflammatory response syndrome (SIRS), 
multiple organ dysfunction syndrome (MODS), multiple organ failure (MOF): are we 
winning the battle? Shock. 1998; 10:79-89. 
5. Vincent JL. Prevention and therapy of multiple organ failure. World J Surg. 
1996;20:465-470. 
6. Waydhas C, Nast-Kolb D, Jochum M, et al. Inflammatory mediators, infection, sepsis, 
and multiple organ failure after severe trauma. Arch Surg. 1992;127:460-467. 
7. Moore FA, Moore EE. Evolving concepts in the pathogenesis of postinjury multiple 
organ failure. Surg Clin North Am. 1995;75:257-277. 
8. Deitch EA. Multiple organ failure: pathophysiology and potential future therapy. Ann 
Surg. 1992;216:117-134. 
9. Baue AE. The horror autotoxicus and multiple-organ failure. Arch Surg. 
1992;127:1451-1462. 
10. Roumen RM, Redl H, Schlag G, et al. Inflammatory mediators in relation to the 
development of multiple organ failure in patients after severe blunt trauma. Crit Care 
Med 1995;23:474-480. 
11. Donnelly TJ, Meade P, Jagels M, et al. Cytokine, complement, and endotoxin profiles 
associated with the development of the adult respiratory distress syndrome after 
severe injury. Crit Care Med. 1994;22:768 -776. 
12. Botha AJ, Moore FA, Moore EE, et al. Early neutrophil sequestration after injury: a 
pathogenic mechanism for multiple organ failure. J Trauma. 1995;39:411-417. 
84 
13. Partrick DA, Moore FA, Moore EE, Barnett CC Jr, Silliman CC. Neutrophil priming 
and activation in the pathogenesis of postinjury multiple organ failure. New Horiz. 
1996;4:194-210. 
14. Fisher CJ Jr, Opal SM, Dhainaut JF, et al. Influence of an anti-tumor necrosis factor 
monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis 
Syndrome Study Group. Crit Care Med. 1993;21:318 -327. 
15. Fisher CJ Jr, Slotman GJ, Opal SM, et al. Initial evaluation of human recombinant 
interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, 
open- label, placebo-controlled multicenter trial. The IL-1RA Sepsis Syndrome Study 
Group. Crit Care Med. 1994;22:12-21. 
16. Fisher CJ Jr, Zheng Y. Potential strategies for inflammatory mediator manipulation: 
retrospect and prospect. World J Surg. 1996;20:447-453. 
17. Guirao X, Lowry SF. Biologic control of injury and inflammation: much more than 
too little or too late. World J Surg. 1996;20:437- 446. 
18. Bone RC, Balk RA, Fein AM, et al. A second large controlled clinical study of E5, a 
monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, 
controlled trial. The E5 Sepsis Study Group. Crit Care Med. 1995;23:994 -1006. 
19. Dofferhoff AS, Bom VJ, de Vries-Hospers HG, et al. Patterns of cytokines, plasma 
endotoxin, plasminogen activator inhibitor, and acute-phase proteins during the 
treatment of severe sepsis in humans. Crit Care Med. 1992; 20:185-192. 
20. Faist E, Schinkel C, Zimmer S. Update on the mechanisms of immune suppression of 
injury and immune modulation. World J Surg. 1996;20:454-459. 
21. Moore FA, Sauaia A, Moore EE, et al: Postinjury multiple organ failure: A bi-modal 
phenomenon. J Trauma 1996;40:501. 
22. Fry DE, Pearlstein L, Fulton RL, et al: Multiple system organ failure: The role of 
uncontrolled infection. Arch Surg 1980;115:136. 
23. Bell RC, Coalson J J, Smith JD, et al: Multiple organ system failure and infection in 
adult respiratory distress syndrome. Ann Intern Med 1983;99:293. 
24. Faist E, Baue AE, Dittmer H, et al: Multiple organ failure in polytrauma patients. J 
Trauma 1983;23:775. 
86 
25. Goris JA, Boekhoerst TP, Nuytinck JK, et al: Multiple organ failure. Arch Surg 
1985; 120:1109. 
26. Sauaia AJ, Moore FA, Moore EE: Multiple organ failure can be predicted as early as 
12 hrs postinjury. J Trauma 45:291, 1998. 
27. Sauaia AJ, Moore FA, Moore EE, et al: Early risk factors for postinjury multiple 
organ failure. World J Surg 20:391, 1996. 
28. Sauaia A, Moore FA, Moore EE et al: Early predictors of postinjury multiple organ 
failure. Arch Surg 129:39, 1994. 
29. Gee MH, Gottieb JE, Albertine KH et al. Physiology of ageing related to outcome in 
adult respiratory distress syndrome. JAppl Physiol. 1990;69:822. 
30. Shoemaker WC, Kram HB, Appel PL. Therapy of shock based on pathophysiology, 
monitoring and outcome prediction. Crit Care Med. 1990; 18:S 19-S25. 
31. Tran DD, Cuesta MA, van Leeuwen PA, Nauta JJ, Wesdorp RI. Risk factors for 
multiple organ system failure and death in critically injured patients. Surgery. 
1993;114:21-30. 
32. Henao FJ, Daes JE, Dennis RJ. Risk factors for multiorgan failure: a case-control 
study. J Trauma. 1991 ;31:74-80. 
33. Copes WS, Champion HR, Sacco WJ, et al. The Injury Severity Score revisited. J 
Trauma. 1988;28:69-77. 
34. Osier T. Injury severity scoring: perspectives in development and future directions. 
Am J Surg. 1993;165:43S-51S. 
35. Copes WS, Champion HR, Sacco WJ, et al. Progress in characterizing anatomic 
injury. J Trauma. 1990;30:1200-1207. 
36. Sacco WJ, Jameson JW, Copes WS, et al. Progress toward a new injury severity 
characterization: severity profiles. Comput Biol Med. 1988;18:419-429. 
37. Champion HR, Copes WS, Sacco WJ, et al. A new characterization of injury severity. 
J Trauma. 1990;30:539-545. 
38. Champion HR, Copes WS, Sacco WJ, et al. Improved predictions from a severity 
characterization of trauma (ASCOT) over Trauma and Injury Severity Score (TRISS): 
results of an independent evaluation. J Trauma. 1996;40:42-48. 
88 
39. Markle J, Cayten CG, Byrne DW, Moy F, Murphy JG. Comparison between TRISS 
and ASCOT methods in controlling for injury severity. J Trauma. 1992;33:326 -332. 
40. Osier T, Baker SP, Long W. A modification of the Injury Severity Score that both 
improves accuracy and simplifies scoring. J Trauma. 1997;43:922-925. 
41. Baker SP, O'Neill B, Haddon W Jr, Long WB. The Injury Severity Score: a method 
for describing patients with multiple injuries and evaluating emergency care. J 
Trauma. 1974;14:187-196. 
42. American Association for Automotive Medicine. The Abbreviated Injury Scale, 1990 
revision. Des Plaines, IL: American Association for Automotive Medicine, 1990. 
43. DeLong ER, DeLong DM, Clarke-Peterson DI. Comparing the area under two or 
more correlated receiver operating curves: a non-parametric approach. Biometrics. 
1988;44:837-845. 
44. Haley J, McNeil B. The meaning and use of the area under a receiver operating 
characteristic (ROC) curve. Radiology. 1982; 143:29-36. 
45. Haley J, McNeil B. A method of comparing the areas under receiving operating 
curves derived from the same cases. Radiology. 1983;148:839-843. 
46. Brenneman FD, Boulanger BR, McLellan BA, Redelmeier DA. Measuring injury 
severity: time for a change? J Trauma. 1998;44:580 -582. 
47. Balogh Z, Offner PJ, Moore EE, et al. NISS predicts postinjury multiple organ failure 
better than the ISS. J Trauma. 2000;48:624-627. 
48. Fern KT, Smith JT, Zee B, et al. Trauma patients with multiple extremity injuries: 
resource utilization and long-term outcome in relation to injury severity scores. J 
49. Glance LG, Osier TM, Dick A, Mukamel D. The relation between trauma center 
outcome and volume in the National Trauma Databank. J Trauma. 2004;56:682-90. 
50. Chiara O, Cimbanassi S. Organized trauma care: does volume matter and do trauma 
centers save lives? Curr Opin Crit Care. 2003;9:510-4. 
51. Poole GV, Tinsley M, Tsae AK, et al. Abbreviated Injury Scale does not reflect the 
added morbidity of multiple lower extremity fractures. J Trauma. 1996;40:951-954. 
52. Sacco WJ, MacKenzie EJ, Champion HR, et al. Comparison of alternative methods 
for assessing injury severity based on anatomic descriptors. J Trauma. 1999;47:441-
447. 
90 
53. Wu CC, Shih CH. Simultaneous bilateral femoral shaft fracture. J Trauma. 
1992;32:289-293. 
54. Suzuki M, Inaunen W, Kvietys PR, et al. Superoxide mediates reperfusion-induced 
injury leukocyte-endothelial cell interactions. Am J Physiol. 1989;257:1667-1673. 
55. Kansas GS. Selectins and their ligands: current concepts and controversies. Blood. 
1996;88:3258-3287. 
56. Koenig A, Norgard-Sumnicht K, Linhardt R, Varki A. Differential interactions of 
heparin and heparan sulfate glycosaminoglycans with the selectins: implications for 
the use of unfractionated and low molecular weight heparins as therapeutic agents.,/ 
Clin Invest. 1998; 101:877-889. 
57. Ley K, Cerrito M, Arfors KE. Sulfated polysaccharides inhibit leukocyte rolling in 
rabbit mesentery venules. Am J Physiol. 1991; 260:H1667-H1673. 
58. Hartl P, Brucke P, Dienstl E, Vinazzer H. Prophylaxis in general surgery: comparison 
between standard heparin and Fragmin. Thromh Res. 1990;57:577-584. 
59. Kakkar VV, Cohen AT, Edmondson RA, et al. Low molecular weight versus standard 
heparin for prevention of venous thromboembolism after major abdominal surgery. 
Lancet. 1993;341:259-265. 
60. Pineo GF, Hull RD. Unfractionated and low-molecular-weight heparin: comparisons 
and current recommendations. Med Clin North Am. 1998;82:587-599. 
61. Wolf H. Low-molecular-weight heparin. Med Clin North Am. 1994; 78:733-743. 
62. Holmer E, Soderberg K, Bergqvist D, et al. Heparin and its low molecular weight 
derivatives: anticoagulant and antithrombotic properties. Haemostasis. 
1986; 16(S2): 1—7. 
63. Bergqvist A. Thromboprophylactic effect of low molecular weight heparin started in 
the evening before general abdominal surgery: a comparison with low-dose heparin. 
Semin Thromb Hemost. 1990; 16:19-24. 
64. Baue AE, Durham RM, Mazuski JE. Clinical trials of new and novel therapeutic 
agents. World J Surg. 1996;20:493^198. 
65. Xie X, Rivier AS, Zakrzewicz A, et al. Inhibition of selectin mediated cell adhesion 
and prevention of acute inflammation by nonanticoagulant sulfated saccharides. J Biol 
Chem. 2000; 275:34818-34825. 
46 
66. Dunn CJ, Sorkin EM. Dalteparin sodium: a review of its pharmacology and clinical 
use in the prevention and treatment of thromboembolic disorders. Drugs. 
1996;52:276-305. 
67. Bratt G, Thörnebohm E, Widlund L, et al. Low molecular weight heparin (Kabi 2165, 
Fragmin): pharmacokinetics after intravenous and subcutaneous administration in 
human volunteers. Thromb Res. 1986;42:613-620. 
68. Dunn CJ, Jarvis B. Dalteparin: an update of its pharmacological properties and 
clinical efficacy in the prophylaxis and treatment of thromboembolic disease. Drugs. 
2000;60:203-237. 
69. American College of Surgeons, Committee on Trauma. Advanced Trauma Life 
Support Program for Doctors, 6th edition, Chicago, American College of Surgeons, 
1997. 
70. Balogh Z, Tomka J, Varga E, Simonka J.A. Advanced Trauma Life Support (ATLS): 
koncepció és ideológia. Magyar Traumatol. Ortop. Kézseb. Plasztikai Seb. 
1999;42:338-344. 
71. Balogh Z, Wolfárd A, Szalay L, Simonka JA, Boros M. Sodium Dalteparin treatment 
during resuscitation inhibits hemorrhagic shock-induced leukocyte rolling and 
adhesion in the mesenteric microcirculation. J Trauma. 2002;52:1062-1070. 
72. Koustova E, Stanton K, Gushchin V, Alam HB, Stegalkina S, Rhee PM. Effects of 
lactated Ringer's solutions on human leukocytes. J Trauma. 2002 ;52:872-8. 
73. Rhee P, Burris D, Kaufmann C, Pikoulis M, Austin B, Ling G, Harviel D, Waxman 
K. Lactated Ringer's solution resuscitation causes neutrophil activation after 
hemorrhagic shock. J Trauma. 1998;44:313-9. 
74. Balogh Z, Varga E, Süveges G, Tomka J. Tóth L, Simonka JA. The New Injury 
Severity Score is a Better Predictor of Extended Hospitalization and ICU Admission 
than the ISS in Patients with Multiple Orthopedic Injuries. J Orthop Trauma. 
2003;7:508-12 
